A review of 606 trial abstracts on diabetic foot reveals persistent gaps in reporting essential research details, despite the publication of reporting guidelines like CONSORT-A, highlighting ongoing challenges in research transparency and clarity.
A new review published by MDPI’s journal Medicina suggests that abstracts of randomised controlled trials on diabetic foot still often omit key information that readers need to judge the quality of the research. The cross-sectional analysis examined 606 trial abstracts indexed in MEDLINE/PubMed between 1994 and 2026 and measured how closely they matched the CONSORT-A reporting checklist for abstracts, a standard designed to improve transparency. The median score was 6 out of 17 items, or 35.29%, pointing to substantial gaps in reporting.
The most common omissions were basic trial details. According to the study, 84.3% of abstracts did not state whether the work was multicentre, and 78.9% involved fewer than 100 participants. Yet some elements were usually present: the objective, intervention and conclusion appeared in more than 90% of abstracts. By contrast, only 3.6% described the randomisation method, 4.8% disclosed funding, 6.8% explained the recruitment process and 7.4% reported the number of analysed participants.
The researchers found that reporting improved after the CONSORT-A statement was published in 2008, with the median score rising to 41.18% from 35.29%. But segmented regression analysis suggested that the improvement reflected a long-running gradual trend rather than a clear step-change linked to the guideline itself. In other words, the paper argues that the field has improved over time, but not because the checklist suddenly changed abstract quality.
That finding fits a wider pattern seen across medical publishing. Previous analyses in general medicine, clinical pathways, psychiatry and other specialties have also found that CONSORT-A can help, but that abstracts still frequently fail to report methodological details such as blinding, allocation concealment and participant numbers. For clinicians and researchers working in diabetic foot care, the message is straightforward: a polished abstract may not provide enough information to support confident interpretation, and the full paper remains essential.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
